A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)

NCT03258814 · clinicaltrials.gov ↗

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Low or No Enrollment

Conditions

Axial Spondyloarthritis

Interventions

BEHAVIORAL: Active Supervised Training (AST)
BEHAVIORAL: Standard of Care (SOC) Physiotherapy

Sponsor

AbbVie